Publication | Closed Access

Unravelling the anticancer potency of 1,2,4-triazole-N-arylamide hybrids through inhibition of STAT3: synthesis and in silico mechanistic studies

Anticancer PotencyCombinatorial ChemistryMedicinal ChemistryMedicinePharmacotherapy1,2,4-Triazole-n-arylamide HybridsAnti-cancer AgentSilico Mechanistic StudiesDrug DevelopmentPharmacologyRadiation OncologyDrug Discovery